Despite a dip in revenue, PRA International saw its profit grow 53
per cent in the fourth quarter of 2005 to reach $7.5m (€6.3m) on
the back of improved margins. The global clinical research
organization (CRO) also saw a similar growth...
Perceptive Informatics, a subsidiary of Parexel, has released the
latest version of its web interface for data capture, patient
randomisation and the management of study drug inventory for
Anachem has just kicked off a unique new European-wide support and
maintenance service for scientific instruments - the first of its
kind - aimed to help instrumentation suppliers wanting to grow
their sales in Europe.
Kendle is further expanding its reach across the globe, targeting
the Asia Pacific and Latin America in its plans for to capitalise
on the Phase I-III clinical development services market, tipped to
reach $3.6bn this year.
In order to stay competitive, Wyeth looks to model its business not
on that of other pharma companies, but of other successful big
industries, which includes outsourcing or off-shoring anything that
is not a core function.
Promed is due to start operations at its new research centre in
India, New Deli, this month, in a move that will bring the company
closer to becoming a global provider of drug development and supply
According to a new report, the adoption of eClinical technologies
has been hampered by the ability to take the electronic revolution
to the next level, as the adoption of eClinical technologies
currently remain confined to localised...
Drug developer Biosante has been awarded a $250,000 (€210,000)
subcontract from the University of Nebraska, Lincoln (UNL), to
develop recombinant Factor IX (FIX) formulations for delivery via
alternative routes of administration,...
Chiltern is expanding its clinical trial services business in
India, and in doing so will be the first company to provide
specialised staff recruitment services for the Indian clinical
Pharsight, a provider of software and strategic services for
clinical drug development, has seen its revenues dip for the second
quarter in a row due to lower-than-expected business from a top
client in its strategic consulting services...
British biotechnology firm Angel has won a manufacturing contract
from stem cell therapeutics expert ReNeuron Group to produce a
master cell bank for Huntington's disease, as the company's demand
for stem cells increases.